The Election Can't Come Soon Enough For Biotechs By: Benzinga via Benzinga November 01, 2016 at 10:39 AM EDT At first glance, the FBI's decision to take a second look into the Hillary Clinton email investigation appeared to benefit the biotech ... Read More >> Related Stocks: Bristol-Myers Squibb Gilead Sciences McKesson Corp Merck & Co Pfizer